MENU CLOSE
About Us

Who We Are

Our Social Responsibility

Events

Exhibitions

Activeties

Members

Hospitals

Individuals

Companies

Member Benefits

 
Bio-medical projectsi

State Key Laboratory of Biotherapy

Cooperation

Achievement Exhibition

Scimea Journals

Signal Transduction and Targeted Therapy

News

News Information

 
Home   >  News
06 Aug 2020
19
MedComm | Regulatory T cells: A potential weapon to combat COVID‐19?
Scimea

Up to May 27th, there are at least 352 460 patients died from COVID-19, attributed to the widely spread novel coronavirus SARS‐CoV‐2. An effective treatment against COVID-19 is desiderated. Song Guo Zheng et al provided a review focused on the roles of immune cells in pathological processes, and the possiblity of attenuating lung symtoms by activating immunosuppressive T regulatory cells in COVID-19 cases.


1600234393(1).png


Since the end of December 2019, a novel coronavirus SARS‐CoV‐2 began to spread, an infection disease termed COVID‐19. The virus has spread throughout the world in a short period of time, resulting in a pandemic. The number of reported cases in global reached 5 695 596 including 352 460 deaths, as of May 27, 2020. Due to the lack of effective treatment options for COVID‐19, various strategies are being tested. Recently, pathologic studies conducted by two teams in China revealed immunopathologic abnormalities in lung tissue (Fig. 1). These results have implications for immunotherapy that could offer a novel therapy strategy for combating lethal viral pneumonia. This review discusses the clinical and pathological features of COVID‐19, the roles of immune cells in pathological processes, and the possible avenues for induction of immunosuppressive T regulatory cells attenuating lung inflammation due to viral infection. It is our hope that these proposals may both be helpful in understanding the novel features of SARS‐CoV‐2 pneumonia as well as providing new immunological strategies for treating the severe sequelae of disease manifestations seen in people infected with SARS‐CoV‐2.

 

 image.png

Fig. 1 Immune response in lung tissues after coronavirus infection.

 


 

                                                                                                                            

Article Access: https://onlinelibrary.wiley.com/doi/10.1002/mco2.12

Website for MedComm: https://onlinelibrary.wiley.com/journal/26882663

Looking forward to your contributions.


MedComm | Metabolism in tumor microenvironment: Implications for cancer immunotherapy
Famous Doctors' Lecture Hall | Wu Kangmin: Nutrition and Feeding for Early Infants
The "2019 Chinese Medicinal Chemistry Symposium" with Nearly 4,000 Participants Successfully Concluded with Experts Comments as Follow...
Interview | Wei Yuquan: China-Japan Biomedical Achievement Transformation Platform Launched
Sichuan University SCI magazine STTT comes as a soaring star
Latest Events Journals News Members About Us Home
Contact Us

Address: No. 1103-1105, Building 6, S2, Global Center, High-tech Zone, Chengdu

Email: scimea@163.com 

Tel: (0086-)028-63859818   

Fax: (0086-)028-63859818   

Contact: (0086-)19113901604 (wechat:19113901604)


Follow Us
Copyright © 2009-2019 SCIMEA. All rights reserved 蜀ICP备19011649号-1